Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart.

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

Risk stratification of patients with chest pain has traditionally focused on identifying obstructive coronary artery disease (CAD). Using this traditional approach, many symptomatic individuals are ...

A special group of drivers have been issued a heads-up about an imminent deadline - yes, that's right all you Amys out there.

Motorists are being alerted to an important date that’s fast-approaching. On social media, the DVLA Personalised Registration ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study showed ...

The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...

Alongside a picture of the plate, it mentioned there is a time limit for anyone interested in it. It added: "It's available ...